Literature DB >> 6351620

Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features.

R L Barbieri, K J Ryan.   

Abstract

The HAIR-AN syndrome that consists of hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN) is an underdiagnosed endocrinopathy, because hyperandrogenic women are not commonly screened for insulin resistance or acanthosis nigricans. The distinct pathophysiologic features of the HAIR-AN syndrome are discussed in detail. In this syndrome, the primary pathophysiologic derangements are the insulin resistance and the hyperandrogenism. The acanthosis nigricans is an epiphenomenon of these primary processes. In patients with the HAIR-AN syndrome, the degree of severity of the insulin resistance is positively correlated with the degree of severity of the hyperandrogenism. In patients with adequate pancreatic beta-islet cell reserve, insulin resistance results in a long-term increase in circulating insulin levels. The hyperinsulinemia probably directly stimulates ovarian androgen production. In turn, hyperandrogenism itself produces insulin resistance. This positive feedback loop between insulin resistance and hyperandrogenism propagates the disease, and increases its severity over time. The relationship between insulin resistance and hyperandrogenism may explain the hyperandrogenemia seen in the following disease processes: obesity, acromegaly, lipoatrophic diabetes, leprechaunism, and Kahn types A and B insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351620     DOI: 10.1016/0002-9378(83)90091-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  28 in total

1.  Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.

Authors:  Steven K Malin; John P Kirwan; Chang Ling Sia; Frank González
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Polycystic ovaries in leprechaunism.

Authors:  Denise Drohobyczer; Richard Bellah
Journal:  Pediatr Radiol       Date:  2009-08-18

Review 3.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

Review 4.  Hirsutism: evaluation and management.

Authors:  R E Watson; R Bouknight; P C Alguire
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

5.  The thrifty genotype and non-insulin dependent diabetes.

Authors:  R Fox
Journal:  BMJ       Date:  1993-04-03

6.  Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.

Authors:  G S Conway; H S Jacobs
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

7.  Surrogate markers of insulin resistance: A review.

Authors:  Bhawna Singh; Alpana Saxena
Journal:  World J Diabetes       Date:  2010-05-15

8.  Racial Disparities between the Sex Steroid Milieu and the Metabolic Risk Profile.

Authors:  Arlette Perry; Xuewen Wang; Ronald Goldberg; Robert Ross; Loreto Jackson
Journal:  J Obes       Date:  2010-07-08

Review 9.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

10.  Bone mineral density in hyperandrogenic amenorrhoea.

Authors:  J Prezelj; A Kocijancic
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.